Previous close | 55.20 |
Open | 55.20 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 530.00 |
Expiry date | 2024-11-15 |
Day's range | 55.20 - 55.20 |
Contract range | N/A |
Volume | |
Open interest | N/A |
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.
McKesson (MCK) closed at $589.95 in the latest trading session, marking a -0.19% move from the prior day.